{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:47:44Z","timestamp":1785739664826,"version":"3.56.0"},"reference-count":50,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background\/Objectives: Glioblastoma multiforme (GB) is an extremely aggressive tumor of the central nervous system, characterized by rapid growth, high invasiveness, and significant resistance to treatment. A growing body of data indicates that metabolic reprogramming of GB cells may be a therapeutic target, and that the ketogenic diet (KD)\u2014by limiting glucose and inducing ketosis\u2014may modulate tumor metabolism. The aim of this review was to provide a synthetic presentation of the current state of knowledge regarding the use of KD as an adjunctive therapy in the treatment of GB, with a particular focus on the mechanisms of action, safety, feasibility and results of clinical trials. Methods: The review was conducted in accordance with the Joanna Briggs Institute methodology and the PRISMA-ScR guidelines. A systematic search of PubMed, Scopus, EBSCO, Web of Science, Google Scholar, and Cochrane Library (1\u201310 April 2026) included studies on the use of KD in patients with GB. Full-text observational studies, randomised trials and reviews were included in the analysis. Data extraction was carried out according to the Population\u2013Concept\u2013Context (PCC) model. Results: Of the 26 publications identified, 12 met the inclusion criteria. Preclinical data consistently indicate that KD may reduce glycolysis, lower insulin and IGF-1 levels, increase oxidative stress in cancer cells, and modulate the inflammatory microenvironment. Clinical trials confirm the safety and feasibility of KD, as well as the ability to maintain stable ketosis. Preliminary data suggest potential metabolic benefits and improved quality of life, however, clinical efficacy remains inconclusive due to small trials, heterogeneous dietary protocols, and a lack of randomized trials. The variety of interventions used (classic KD; MCT-KD-Medium-chain triglyceride KD; KD-IF\u2014KD and intermittent fasting) makes it difficult to compare the results. Conclusions: The KD represents a promising, low-toxic strategy to support the treatment of GB, based on biological basis. Available data indicate its safety and feasibility, but there is insufficient evidence to recommend its routine use in clinical practice. Large, multicenter, randomized trials with standardized dietary protocols and objective monitoring of metabolic parameters are needed to unambiguously assess the impact of KD on disease survival and progression.<\/jats:p>","DOI":"10.3390\/nu18152498","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:17:40Z","timestamp":1785737860000},"page":"2498","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic Therapy in Glioblastoma\u2014Mapping the Evidence for Ketogenic Diet as an Adjunctive Strategy"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6459-3844","authenticated-orcid":false,"given":"Dominika","family":"Wi\u015bniewska","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Collegium Medicum, University of Rzesz\u00f3w, 35-310 Rzeszow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2387-8958","authenticated-orcid":false,"given":"Martyna","family":"Winiarska","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Collegium Medicum, University of Rzesz\u00f3w, 35-310 Rzeszow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3002-3153","authenticated-orcid":false,"given":"Sabina","family":"Krupa-Nurcek","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine, Collegium Medicum, University of Rzesz\u00f3w, 35-310 Rzeszow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-025-02267-0","article-title":"Glioblastoma multiforme: Insights into pathogenesis, key signaling pathways, and therapeutic strategies","volume":"24","author":"Pouyan","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000531319","article-title":"Glioblastoma Multiforme: The Latest Diagnostics and Treatment Techniques","volume":"108","author":"Czarnywojtek","year":"2023","journal-title":"Pharmacology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.3390\/curroncol31070296","article-title":"Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme-A Literature Review and Clinical Outcomes","volume":"31","author":"Nafalska","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Huang, B., Li, X., Li, Y., Zhang, J., Zong, Z., and Zhang, H. (2021). Current Immunotherapies for Glioblastoma Multiforme. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.603911"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mahmoud, A.B., Ajina, R., Aref, S., Darwish, M., Alsayb, M., Taher, M., AlSharif, S.A., Hashem, A.M., and Alkayyal, A.A. (2022). Advances in immunotherapy for glioblastoma multiforme. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.944452"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.32604\/or.2024.049538","article-title":"Ketogenic diet with oxyresveratrol and zinc inhibits glioblastoma and restores memory function and motor coordination","volume":"33","author":"Gujaran","year":"2025","journal-title":"Oncol. Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Valerio, J., Borro, M., Proietti, E., Pisciotta, L., Olarinde, I.O., Fernandez Gomez, M., and Alvarez Pinzon, A.M. (2024). Systematic Review and Clinical Insights: The Role of the Ketogenic Diet in Managing Glioblastoma in Cancer Neuroscience. J. Pers. Med., 14.","DOI":"10.3390\/jpm14090929"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/CEJ.0000000000000918","article-title":"The effects of the ketogenic diet on cancer treatment: A narrative review","volume":"34","author":"Deng","year":"2025","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40170-020-00230-9","article-title":"Treatment of glioblastoma multiforme with \u201cclassic\u201d 4:1 ketogenic diet total meal replacement","volume":"8","author":"Klein","year":"2020","journal-title":"Cancer Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"21064","DOI":"10.1038\/s41598-025-06675-6","article-title":"A phase 1 safety and feasibility trial of a ketogenic diet plus standard of care for patients with recently diagnosed glioblastoma","volume":"15","author":"Amaral","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Dal Bello, S., Valdemarin, F., Martinuzzi, D., Filippi, F., Gigli, G.L., and Valente, M. (2022). Ketogenic Diet in the Treatment of Gliomas and Glioblastomas. Nutrients, 14.","DOI":"10.3390\/nu14183851"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Munn, Z., Peters, M., Cindy, S., Catalin, T., McArthur, A., and Aromataris, E. (2018). Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med. Res. Methodol., 18.","DOI":"10.1186\/s12874-018-0611-x"},{"key":"ref_13","unstructured":"Peters, M., Godfrey, C., McInerney, P., Baldini Soares, C., Khalil, H., and Parker, D. (2015). The Joanna Briggs Institute Reviewers\u2019 Manual 2015: Methodology for JBI Scoping Reviews, Joanna Briggs Institute."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Aromataris, E., and Munn, Z. (2020). Chapter 11: Scoping Reviews (2020 version). JBI Manual for Evidence Synthesis, Joanna Briggs Institute.","DOI":"10.46658\/JBIRM-17-01"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11060-020-03417-8","article-title":"Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): A randomized, mixed methods, feasibility study","volume":"147","author":"Marson","year":"2020","journal-title":"J. Neuro-Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00394-021-02666-1","article-title":"Short-term fasting in glioma patients: Analysis of diet diaries and metabolic parameters of the ERGO2 trial","volume":"61","author":"Voss","year":"2022","journal-title":"Eur. J. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Sarga\u00e7o, B., Oliveira, P.A., Antunes, M.L., and Moreira, A.C. (2022). Effects of the Ketogenic Diet in the Treatment of Gliomas: A Systematic Review. Nutrients, 14.","DOI":"10.3390\/nu14051007"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Montella, L., Sarno, F., Altucci, L., Cioffi, V., Sigona, L., Di Colandrea, S., De Simone, S., Marinelli, A., Facchini, B.A., and De Vita, F. (2021). A Root in Synapsis and the Other One in the Gut Microbiome-Brain Axis: Are the Two Poles of Ketogenic Diet Enough to Challenge Glioblastoma?. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.703392"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Duraj, T., Kalamian, M., Zuccoli, G., Maroon, J.C., D\u2019Agostino, D.P., Scheck, A.C., Poff, A., Winter, S.F., Hu, J., and Klement, R.J. (2024). Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma. BMC Med., 22.","DOI":"10.1186\/s12916-024-03775-4"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12032-025-03165-7","article-title":"Efficacy of ketogenic metabolic therapy as an adjuvant to the current standard of care in the treatment of glioblastoma: A systematic review of clinical trials","volume":"43","author":"McKerill","year":"2025","journal-title":"Med. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.critrevonc.2017.02.016","article-title":"Role of ketogenic metabolic therapy in malignant glioma: A systematic review","volume":"112","author":"Winter","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"CNS17","DOI":"10.2217\/cns-2017-0030","article-title":"The role of ketogenic diets in the therapeutic management of adult and paediatric gliomas: A systematic review","volume":"7","author":"Srikandarajah","year":"2018","journal-title":"CNS Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.clnu.2018.10.024","article-title":"Treatment of malignant gliomas with ketogenic or caloric restricted diets: A systematic review of preclinical and early clinical studies","volume":"38","author":"Noorlag","year":"2019","journal-title":"Clin. Nutr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11060-014-1362-0","article-title":"Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme","volume":"117","author":"Champ","year":"2014","journal-title":"J. Neuro-Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11060-021-03786-8","article-title":"A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade glioma","volume":"153","author":"Porper","year":"2021","journal-title":"J. Neuro-Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1758835919853958","DOI":"10.1177\/1758835919853958","article-title":"Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: A feasibility and safety study","volume":"11","author":"Olieman","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s42003-019-0455-x","article-title":"Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma","volume":"2","author":"Mukherjee","year":"2019","journal-title":"Commun. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1177\/0883073813488670","article-title":"Restricted calorie ketogenic diet for the treatment of glioblastoma multiforme","volume":"28","author":"Maroon","year":"2013","journal-title":"J. Child Neurol."},{"key":"ref_30","first-page":"e251","article-title":"The Efficacy of Ketogenic Diet and Associated Hypoglycemia as an Adjuvant Therapy for High-Grade Gliomas: A Review of the Literature","volume":"7","author":"Varshneya","year":"2015","journal-title":"Cureus"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kesarwani, P., Kant, S., Zhao, Y., Miller, C.R., and Chinnaiyan, P. (2022). The Influence of the Ketogenic Diet on the Immune Tolerant Microenvironment in Glioblastoma. Cancers, 14.","DOI":"10.3390\/cancers14225550"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/01635581.2018.1460677","article-title":"The Modified Ketogenic Diet in Adults with Glioblastoma: An Evaluation of Feasibility and Deliverability within the National Health Service","volume":"70","author":"Marson","year":"2018","journal-title":"Nutr. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00429-020-02111-9","article-title":"MRI spectroscopic and tractography studies indicate consequences of long-term ketogenic diet","volume":"225","author":"Janeczko","year":"2020","journal-title":"Brain Struct. Funct."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1758835919882584","DOI":"10.1177\/1758835919882584","article-title":"Author response to \u2018Problems associated with a highly artificial ketogenic diet: Letter to the Editor Re: Van der Louw EJTM, Olieman JF, van den Bemt PMLA; et al. \u201cKetogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: A feasibility and safety study\u201d\u2019","volume":"11","author":"Olieman","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kiryttopoulos, A., Evangeliou, A.E., Katsanika, I., Boukovinas, I., Foroglou, N., Zountsas, B., Cheva, A., Nikolopoulos, V., Zaramboukas, T., and Duraj, T. (2025). Corrigendum: Successful application of dietary ketogenic metabolic therapy in patients with glioblastoma: A clinical study. Front. Nutr., 12, Erratum in Front. Nutr.\u00a02025, 11, 1489812. https:\/\/doi.org\/10.3389\/fnut.2024.1489812.","DOI":"10.3389\/fnut.2025.1614194"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1743-7075-7-33","article-title":"Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report","volume":"7","author":"Zuccoli","year":"2010","journal-title":"Nutr. Metab."},{"key":"ref_37","first-page":"1263","article-title":"Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma","volume":"15","author":"Santos","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Elsakka, A.M.A., Bary, M.A., Abdelzaher, E., Elnaggar, M., Kalamian, M., Mukherjee, P., and Seyfried, T.N. (2018). Management of Glioblastoma Multiforme in a Patient Treated with Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up. Front. Nutr., 5.","DOI":"10.3389\/fnut.2018.00020"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"eado1463","DOI":"10.1126\/sciadv.ado1463","article-title":"Ketogenic diet induces p53-dependent cellular senescence in multiple organs","volume":"10","author":"Wei","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1681\/ASN.2020010028","article-title":"The Effects of High-Protein Diets on Kidney Health and Longevity","volume":"31","author":"Ko","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Venturini, C., Matacchione, G., Mancinelli, L., Caccese, S., Alfieri, M., Lattanzio, F., Olivieri, F., and Antonicelli, R. (2026). The Role of Ketogenic Diet and \u03b2-Hydroxybutyrate in the Prevention of Muscle Catabolism and Sarcopenia in Aging Populations: Mechanisms, Evidence, and Clinical Perspectives. Nutrients, 18.","DOI":"10.3390\/nu18050761"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e14284","DOI":"10.1111\/acel.14284","article-title":"Histone \u03b2-hydroxybutyrylation is critical in reversal of sarcopenia","volume":"23","author":"Wang","year":"2024","journal-title":"Aging Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"C140","DOI":"10.1152\/ajpcell.00471.2023","article-title":"Exogenous ketone esters as a potential therapeutic for treatment of sarcopenic obesity","volume":"327","author":"Deemer","year":"2024","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Tamraz, M., Al Ghossaini, N., and Temraz, S. (2023). The Ketogenic Diet in Colorectal Cancer: A Means to an End. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043683"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/cimb43020042","article-title":"Ketogenic Diet in Cancer Prevention and Therapy: Molecular Targets and Therapeutic Opportunities","volume":"43","author":"Talib","year":"2021","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"115866","DOI":"10.1016\/j.psychres.2024.115866","article-title":"Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial","volume":"335","author":"Sethi","year":"2024","journal-title":"Psychiatry Res."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Monda, A., La Torre, M.E., Messina, A., Di Maio, G., Monda, V., Moscatelli, F., De Stefano, M., La Marra, M., Padova, M.D., and Dipace, A. (2024). Exploring the ketogenic diet\u2019s potential in reducing neuroinflammation and modulating immune responses. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1425816"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"14324","DOI":"10.3390\/cimb46120859","article-title":"Towards Effective Treatment of Glioblastoma: The Role of Combination Therapies and the Potential of Phytotherapy and Micotherapy","volume":"46","author":"Gaiaschi","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s10495-023-01857-x","article-title":"Study on the activation of cell death mechanisms: In search of new therapeutic targets in glioblastoma multiforme","volume":"28","author":"Gaiaschi","year":"2023","journal-title":"Apoptosis"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Gaiaschi, L., De Luca, F., Roda, E., Ferrari, B., Casali, C., Inguscio, C.R., Gola, F., Pelloni, E., Savino, E., and Ravera, M. (2024). A Phyto-mycotherapeutic Supplement, Namely Ganostile, as Effective Adjuvant in Brain Cancer Management: An In Vitro Study Using U251 Human Glioblastoma Cell Line. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25116204"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/15\/2498\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:30:35Z","timestamp":1785738635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/15\/2498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":50,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["nu18152498"],"URL":"https:\/\/doi.org\/10.3390\/nu18152498","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]}}}